“…1) is based on a machine learning framework and involves the analysis of a time series of US frames, captured following insonification of tissue over a short period of time, to extract tissue-specific information. Over the last decade, TeUS has been used for characterization of PCa in ex vivo [23,24] and in vivo studies [5,6,16,17,25], with reported areas under the receiver operating characteristic curve (AUC) of 0.76–0.93 [16,17]. Despite significant success of TeUS in research studies, its dissemination to clinical end-users demands multicenter studies to assess robustness and versatility.…”